NCT02565732

Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Primary Axillary Hyperhidrosis

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 67 (actual)
• Sponsor: Revance Therapeutics, Inc. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is a safety and efficacy study of botulinum toxin type A in subjects with primary axillary hyperhidrosis.

Conditions

• Hyperhidrosis

Interventions

Type	Name	Description
BIOLOGICAL	Botulinum toxin type A	Botulinum toxin type A, Dose A, Topical
BIOLOGICAL	Botulinum toxin type A	Botulinum toxin type A, Dose B, Topical
BIOLOGICAL	Placebo comparator	Placebo, Dose C, Topical

Timeline

• Start date: 2015-09-01
• Primary completion: 2015-12-01
• Completion: 2016-01-01
• First posted: 2015-10-01
• Last updated: 2016-08-04

Locations

1 site across 1 country: United States